# Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers

> **NCT01159015** · PHASE3 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 534 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** KetoNaph
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT01159015
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-09
- **Final completion:** 2010-10
- **Target enrollment:** 534 (ACTUAL)
- **Last updated:** 2020-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01159015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01159015, "Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01159015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*